The University of Chicago Header Logo

Connection

Seiko Diane Yamada to Angiogenesis Inhibitors

Back to Details
This is a "connection" page, showing publications Seiko Diane Yamada has written about Angiogenesis Inhibitors.
Seiko Diane Yamada
Connection Strength
0.098
Angiogenesis Inhibitors
  1. Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: results of a phase 2 trial of the Gynecologic Oncology Group. Cancer. 2014 Feb 01; 120(3):344-51.
    View in: PubMed
    Score: 0.098
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.